Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Exelon recommended by FDA Advisory Committee for additional indication

May 18, 2006

FDA approves Cesamet for cancer chemotherapy-associated nausea and vomiting

May 18, 2006

Jurnista completes European mutual recognition procedure

May 18, 2006

Axonyx completes phase I clinical trial with Posiphen

May 18, 2006

TorreyPines Therapeutics' tezampanel completes phase I trials for acute migraine

May 18, 2006

Dextromethorphan/quinidine improves pseudobulbar affect in multiple sclerosis

May 18, 2006

Kadian effective in treating non-malignant pain

May 18, 2006

Eisai begins mutual recognition procedure in U.K. for new Aricept indication

May 17, 2006

Neurocrine receives approvable and nonapprovable letters from FDA for indiplon for insomnia

May 17, 2006

Rosiglitazone neuroprotective in mouse model of cerebral ischemia

May 17, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...